Last updated 8 days ago

Pharmacokinetic Similarity Between ABP 234 and Keytruda® (Pembrolizumab)

154 patients around the world

Available in Chile

Amgen

2Research sites

154Patients around the world

This study is for people with

Lung cancer

Non-small cell lung carcinoma

Requirements for the patient

To 99 Years

All Gender

Medical requirements

Sites

Centro de Investigaciones Clínicas Viña Del Mar

Recruiting

Anabaena 336, Viña del Mar, Valparaíso

Centro Oncológico y Tratamiento Oncología - CDIEM

Recruiting

María Luisa Santander 485, 7500859 Providencia, Región Metropolitana, Chile

StudyEucalyptus

SponsorAmgen

Conditions

Non-small cell lung carcinoma

Requirements

To 99 YearsAll Gender

Unique study IDclinicaltrials.gov

NCT06430866